Celecoxib, commonly known by its brand name Celebrex, is a nonsteroidal anti-inflammatory drug (NSAID) that is primarily used to manage pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, and acute pains, among other conditions. It is primarily prescribed to manage the pain associated with osteoarthritis, rheumatoid arthritis, and primary dysmenorrhea. As an effective pain medication, Celecoxib helps alleviate symptoms of pain and inflammation by reducing production of pain-inducing chemicals (i.e., pain-killing hormones) that promote joint function and swelling.
The global Celecoxib market is experiencing significant growth, driven by several key factors. As of 2023, the market size was valued at USD 970.53 million and is expected to grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2030. Here is a brief overview of the market and the key players:
The COVID-19 pandemic has had a mixed impact on the market, with a smaller impact on the general population. Celecoxib remains a vital component in managing and improving pain, with significant market growth expected from its effectiveness and adoption in the management of acute pain. Here are some key statistics related to the market:
Celecoxib capsules should be taken with food or milk, preferably on an empty stomach.
Celecoxib capsules may be taken with or without food, but it is important that you do not eat or drink heavy meals prior to taking Celebrex. Your doctor will advise you on the correct dosage of Celebrex if you are on a high or low dose of this medication.
Celecoxib capsules can be taken with or without food, but it is important that you do not eat or drink heavy meals prior to taking Celebrex. If you do eat or drink heavy meals, it is likely that you will not take Celebrex. Do not stop taking Celebrex, even if you feel better, as it may take longer to start working.
Take Celebrex with food or milk as long as you follow the instructions on the label. If you have a stomach ulcer or other medical reason for ulcers, Celebrex should be used with caution. If you are taking aspirin to prevent bleeding, you should take Celebrex with a non-aspirin aspirin at the same time each day. It is important to continue taking Celebrex, even if you start to feel better, and you should take Celebrex with a non-aspirin aspirin at the same time each day.
Tell your doctor if you are taking any of the following:
Celebrex can only be used if you are a candidate for this medication. Do not stop taking Celebrex without speaking to your doctor.
If you forget a dose of Celebrex, take it as soon as you remember. However, if it is almost time for the next dose, skip the dose you missed. Do not take two doses at once.
If you are taking Celebrex for the first time, ask your doctor for advice. They will be able to advise you on the correct dose of Celebrex.
Celebrex is rapidly and extensively absorbed, so you may not notice any effects for a period of time. However, some people find that their pain or fever does not persist for days to weeks after taking Celebrex.
Celebrex has been associated with serious side effects. Stop taking Celebrex and get medical help right away if you have any of the following symptoms:
Celebrex can cause a severe and potentially life-threatening allergic reaction.
It is important to note that Celebrex does not prevent the development of cancer. It is therefore important that you do not take Celebrex without talking to your doctor.
Your doctor will decide the dosage of Celebrex based on your medical history and symptoms. You should not take Celebrex if you are taking a low-dose of Celebrex, because it may take longer for the pain, nausea, or other side effects to improve.
Celebrex is quickly absorbed. It is important that you take Celebrex with food or milk as long as it is taken on an empty stomach.
Celebrex is only for short periods of time.
PITTSBURGH, April 17, 2015 /PRNewswire/ -- Mylan Inc., part of the North America and European Company Group (NACOG), today announced it has entered into a definitive agreement with GlaxoSmithKline (NYSE: GSK) to develop and commercialize a new formulation of the pain reliever celecoxib, which is the first of its kind that combines the nonsteroidal anti-inflammatory drugs (NSAIDs) celecoxib and diclofenac with a nonsteroidal anti-inflammatory (NSAID) for the treatment of osteoarthritis. The new formulation, developed through Mylan's development and commercialization program, will be made available to consumers in the United States and Europe through the U. S. Food and Drug Administration (FDA). Mylan is seeking FDA approval for its generic version of celecoxib, which will compete with the new formulation in the U. market. The U. generic celecoxib version, which will be marketed by GlaxoSmithKline under the trade name Celebrex, is available in the U. for $4.37 per dose, while the U. generic diclofenac will be available for $2.50 per dose, or approximately $0.60 per dose in the U. As a generic version of celecoxib, Mylan will continue to market the product in the U.
Mylan Inc. was the global leader in prescription drugs, selling more than 3.1 billion dollars in value in 2015, and the largest pharmaceutical company in the U. with revenues of $5.4 billion. The company is an affiliate of the European Commission for the promotion of the Company and is an equity partner of the U. Securities and Exchange Commission (SEC). The Company's U. sales are $4.3 billion in 2015. It is the only pharmaceutical company that markets prescription drugs in the U. and is the world's largest manufacturer of prescription drugs, with an estimated $9.1 billion in annual sales.
In addition to its product portfolio, Mylan is developing a new formulation of the pain reliever celecoxib, called a rofecoxib capsule, which will be available in the U. in the second half of 2014. The rofecoxib capsule formulation is designed to relieve pain by blocking the inflammatory response in the body, which is the primary driver of arthritis pain and stiffness. Celecoxib belongs to the class of non-steroidal anti-inflammatory drugs (NSAIDs), which have been widely used for decades to treat arthritis and other inflammatory conditions. Its ability to inhibit COX-2, a key component in the body's inflammatory response, makes it a highly effective pain reliever, yet it can be taken by mouth or on an empty stomach, as directed by a healthcare professional. It is available in 50 mg, 100 mg, 200 mg, and 400 mg capsules.
Mylan's research and development and commercialization plan includes developing a new formulation of the pain reliever celecoxib for the treatment of osteoarthritis in the United States. It is expected to launch in the second half of 2014. Mylan's U. patent covering the drug's ability to reduce the risk of cardiovascular events from cardiovascular disease has expired, making it a first-line treatment for osteoarthritis in the United States. Additionally, in the U. S., the U. patent covering the COX-2 inhibitor celecoxib is expected to expire in 2014, making it a second-line treatment for the disease. Mylan is also expected to begin commercializing the rofecoxib capsule formulation in the second half of 2014.
operates its businesses in over 150 countries and is a leading global pharmaceutical company with operations in more than 140 countries. It is the world's leading manufacturer of prescription medications. It is the world's leading manufacturer of generic pharmaceutical products, as well as the world's largest generic pharmaceutical firm. sales in the U. range from $4.7 billion to $8.4 billion.
Mylan has more than 30 years of experience in the medical and pharmaceutical industry, including 15 years as a major player in healthcare, and has been a leading player in the biotechnology and biotechnology innovation, pharmaceutical, and biopharmaceutical industry. For more information, visit.For additional information, visit
SOURCE Mylan Inc.
GlaxoSmithKline NACOG Corp. (NYSE: GSK):PITTSBURGHUpdated April 15, 2015. Updated for BRICGESECT.Celebrex 200mg Capsule is a pain-relieving product that contains Celebrex which belongs to the class of non-steroidal anti-inflammatory drugs. It is used to reduce pain, swelling, and stiffness caused by inflammation in the body. It reduces the production of inflammatory substances in the body that lead to pain, swelling, and stiffness in patients with painful tissue around the body (such as the brain, joints, muscles, and bones).
Celebrex 200mg Capsule is a medicine that contains a mixture of celecoxib, a drug used to treat pain and inflammation. It is used to relieve pain and swelling (swelling of the joints and muscles) caused by conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, the common cold, pain from a cuts and scraped conclude, pemphigus, acute pain, throbbing pain, pain due to acute pains, and menstrual cramps.
Celebrex 200mg Capsule is not an analgesic and antipyretic drug, it is a non-steroidal anti-inflammatory drug (NSAID). Its action helps reduce pain, swelling, and pain during and/or after activities like: dosing, activities, surgical procedures, and procedures that are needed most in the healing of tissues around the body (such as brain, joints, muscles, and bones).
It is a prescription-only medicine and should not be taken more than once a day.
It is not recommended for use in patients with a known hypersensitivity to celecoxib or any other components of the composition of this medicine. It should be used with caution in patients with a history of asthma, hypersensitivity to any medicine contained in this medicine, previous history of heart attack or stroke, myocardial infarction within the past 6 months, or within the last 6 months.
It should be used with caution in patients with a history of liver problems, including asthma, due to its potential to affect the safety and efficacy of celecoxib. It can be crushed in the mouth, and it is not intended for use in patients with a known history of liver problems.
Before taking Celebrex 200mg Capsule, tell your doctor if you are pregnant or are planning to become pregnant or if you are breastfeeding. It should not be given to a child.
ReferencesCelebrex medicine price cvs. (Accessed May 25)This is not a complete list of all products that may contain hidden costs associated with our users. Always consult your doctor for complete information regarding the drugs you are considering taking.
Stade de France Pharmacy